Fungal Pathogens: From Basic Biology to Drug Discovery
joint with Drug Discovery for Protozoan Parasites
Organizer(s): Joseph Heitman, John Taylor and Leah E. CowenDate: January 15 - 20, 2012
Location: Santa Fe Community Convention Center, Santa Fe, NM, USA
The aim of this meeting is to bring together the academic, medical and pharmaceutical communities focused on fungal microbial pathogens of humans and other animals to illustrate common themes, and therapeutic, diagnostic and preventive opportunities. We seek to bridge both basic and physician-scientists working on the pathogenic microbe (via genetics, cell biology, genomics) and the host (immunology, including both innate and adaptive immunity). With respect to therapeutics, the emphasis is on developed as well as novel therapeutics, including both drugs and vaccines. A key aspect is to bridge the communities working on the diversity of fungi that infect humans and those working on the chytrid outbreak causing amphibian decline and extinctions. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Drug Discovery for Protozoan Parasites, which will share the keynote address and two plenary sessions with this meeting.
Global Health Travel Award Deadline: August 16 2011
Scholarship Deadline: September 19 2011
Discounted Abstract Deadline: September 19 2011
Abstract Deadline: October 19 2011
Discounted Registration Deadline: November 15 2011
We gratefully acknowledge additional support for this conference from:
Department of Molecular Genetics and Microbiology, Duke University Medical Center
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Anacor Pharmaceuticals, Inc.
Adriana Secatto Sarti
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI098158-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.